NV-ISACA
15.10.2018 15:37:05 CEST | Business Wire | Press release
With cybersecurity threats continuing to escalate worldwide, the ISACA/CMMI Institute Cybersecurity Culture Report found that just 5 percent of employees think their organization’s cybersecurity culture is as advanced as it needs to be to protect their business from internal and external threats. More than 4,800 business and technology professionals shared their insights in the global research study, conducted via online polling in June 2018. Results were released today at ISACA’s CSX North America cybersecurity conference in Las Vegas.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181015005149/en/
Cybersecurity culture is a workplace culture in which security awareness and behaviors are integrated into everyone’s daily operations, as well as an executive leadership priority. In a threat-ripe environment, an effective cybersecurity culture can help employees understand their roles and responsibilities in keeping their organizations safe and customer data secure. However, just 34 percent of respondents say they understand their role in their organizations’ cyber culture.
Companies must take an all-hands-on-deck approach to counter cyberattack threats, the report summarizes.
“Enlisting the entire workforce to mitigate an enterprise’s cyber risk is an emerging practice,” says Doug Grindstaff II, SVP of Cybersecurity Solutions at CMMI Institute . “We are hearing a lot of feedback about how organizations can move the needle on employee involvement. It’s challenging, but organizations are rightly concerned by the growing sophistication of cyberattacks.”
Widespread employee involvement correlates strongly with the minority of organizations that have achieved strong satisfaction with their cybersecurity culture. Nine in ten employees (92 percent) at these organizations say that their C-level executives share an excellent understanding of the underlying issues, which may be why they loop-in their employees so well; 84 percent of employees at these organizations say they understand their role in cybersecurity.
Other critical findings include:
- Many organizations lack the first—and all-important—step toward a cybersecurity culture: 42 percent of organizations do not have an outlined cybersecurity culture management plan or policy.
- Aligning the entire workforce with the organization’s cybersecurity policies requires significant capital: Organizations that report a significant gap between their current and desired cybersecurity culture are spending just 19 percent of their annual cybersecurity budget on training and tools; organizations that believe their cybersecurity culture is where it is supposed to be are spending more than twice as much (43 percent).
“A key motivator for organizations delaying investing in their cybersecurity cultures is a lack of awareness about the attempted threats and ongoing risks, as well as a lack of awareness about the assets at risk to cybersecurity threats,” said Rob Clyde, NACD Board Leadership Fellow and ISACA Board Chair. “However, individuals tend to underestimate the potential damage and overestimate technology’s ability to limit such incidents. Doing so puts their organizations at serious risk.”
To view the research, visit www.isaca.org/cybersecurity-culture-study .
About ISACA
Nearing its 50th year, ISACA ® (isaca.org ) is a global association helping individuals and enterprises achieve the positive potential of technology. ISACA equips professionals with the knowledge, credentials, education and community to advance their careers and transform their organizations.
Twitter: www.twitter.com/ISACANews
About CMMI ® Institute
A subsidiary of ISACA Enterprises, CMMI Institute (cmmiinstitute.com ) is the global leader in the advancement of best practices in people, process and technology. The Institute provides the tools and support for organizations to benchmark their capabilities and maturity by comparing their operations to best practices and identifying performance gaps.
Twitter: https://twitter.com/CMMI_Institute
View source version on businesswire.com: https://www.businesswire.com/news/home/20181015005149/en/
Contact:
ISACA Emily Van Camp, +1.847.385.7223 evcamp@isaca.org or Kristen Kessinger, +1.847.660.5512 kkessinger@isaca.org
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
